U.S. markets closed

Varian Medical Systems, Inc. (VAR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
172.80+0.52 (+0.30%)
At close: 4:04PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/30/2020
Current
9/30/20206/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
15.71B15.68B11.13B9.31B12.91B10.81B
Enterprise Value 3
15.40B15.59B11.08B9.22B12.79B10.69B
Trailing P/E
58.6059.7248.6233.9944.6632.45
Forward P/E 1
31.2531.2522.2220.4928.3323.75
PEG Ratio (5 yr expected) 1
3.543.542.642.443.382.83
Price/Sales (ttm)
4.984.923.382.854.053.48
Price/Book (mrq)
7.578.115.985.047.306.20
Enterprise Value/Revenue 3
4.8618.3315.9611.6115.4312.17
Enterprise Value/EBITDA 6
36.24126.7799.19113.1589.6870.31

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 339.72%
S&P500 52-Week Change 36.23%
52 Week High 3176.19
52 Week Low 389.62
50-Day Moving Average 3172.26
200-Day Moving Average 3143.56

Share Statistics

Avg Vol (3 month) 31.65M
Avg Vol (10 day) 31.01M
Shares Outstanding 591.16M
Float 90.81M
% Held by Insiders 10.38%
% Held by Institutions 194.63%
Shares Short (Oct 14, 2020) 45.28M
Short Ratio (Oct 14, 2020) 44.12
Short % of Float (Oct 14, 2020) 47.43%
Short % of Shares Outstanding (Oct 14, 2020) 45.79%
Shares Short (prior month Sep 14, 2020) 44.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 01, 1998
Last Split Factor 210000:8769
Last Split Date 3Jan 29, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Oct 01, 2020
Most Recent Quarter (mrq)Oct 01, 2020

Profitability

Profit Margin 8.50%
Operating Margin (ttm)13.41%

Management Effectiveness

Return on Assets (ttm)6.20%
Return on Equity (ttm)13.95%

Income Statement

Revenue (ttm)3.17B
Revenue Per Share (ttm)34.85
Quarterly Revenue Growth (yoy)-3.20%
Gross Profit (ttm)1.38B
EBITDA 522.8M
Net Income Avi to Common (ttm)269.2M
Diluted EPS (ttm)2.94
Quarterly Earnings Growth (yoy)8.30%

Balance Sheet

Total Cash (mrq)766.1M
Total Cash Per Share (mrq)8.41
Total Debt (mrq)456.1M
Total Debt/Equity (mrq)21.88
Current Ratio (mrq)1.40
Book Value Per Share (mrq)22.78

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A